President, European Patients' Forum
Anders Olauson was involved in the founding of the Agrenska Centre in 1989. He served as director until 2004 and since then has been chairman and chief executive officer. He is responsible for establishing The Agrenska Virtual International Academy, a research centre for rare disorders.
Anders is particularly concerned with the impact of rare conditions on children and their families. His work involves contact with both national and regional legislative bodies on the subject of rare disorders. He is also in contact with representatives of hospitals, education and labor unions as well as other key players in the field of rare diseases.
Anders has been a member of the board of Eurordis from 1999 until 2010, and was president from 1999 to 2001. He currently represent Eurordis as a member of the board of the European Patients' Forum (EPF). He has been president of EPF since June 2005.
Anders represented EPF in both steering committee and at The Pharmaceutical Forum, which was established by DG Sanco and DG Enterprise in 2005.
Agrenska was in 2005 appointed member of ECOSOC within United Nations, with "special consultative status".
Since 2006 Anders is a member of the advisory group for Health Research within DG Research. In 2005 Anders was accepted as a researcher within the PhD program at Gothenburg University.
The Swedish Government appointed Anders September 15th 2008, to be a member of the Advisory Council at The National Board of Health and Welfare.
Anders Olauson received HM The King of Sweden's Medal for his valuable contributions in the field of disability. Anders was presented with the King's medal 8th size, with the Seraphim Ribbon at the Royal Palace in Stockholm, the 28th of January 2010.